News and Announcements
Proteomics Share Purchase Plan Offer Document
- Published December 08, 2016 10:10AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th December 2016 – ASX Announcement
Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to present to you the opportunity to apply to increase your investment in the Company through an offer of shares under the Company’s Share Purchase Plan (SPP).
As announced on 2 December 2016, the Company has successfully completed an oversubscribed placement raising $1.44 million at $0.24 per share to existing and new sophisticated investors. PILL also announced an SPP for existing shareholders to raise up to $480,000.
The SPP is offered exclusively to all eligible shareholders who have an address in Australia or New Zealand and who were recorded on the Company register at 5:00 pm (AWST) on 1 December 2016 (Eligible Shareholders). The SPP provides Eligible Shareholders with an opportunity to buy a parcel of new shares in the Company with no brokerage or commission costs, irrespective of the size of their shareholding, up to a maximum value of $15,000.
To view the full announcement, please click on the button below.
If you would like to receive more information about Proteomics, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
